Nebenwirkungen · Cerezyme
Cerezyme 400 Units Powder for concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 5–6
HOS-087505 · Präparat HOS-083519
5 MedDRA System Common Uncommon Rare Not known Organ Class Nervous system Dizziness, disorders headache, paraesthesia Cardiac disorders Tachycardia, cyanosis Vascular Flushing, Transient disorders hypotension hypertension Respiratory, Dyspnoea, coughing thoracic and mediastinal disorders Gastrointestinal Vomiting, disorders nausea, abdominal cramping, diarrhoea Immune system Hypersensitivity Anaphylactoid disorders reactions reactions Skin and Urticaria, angioedema, subcutaneous pruritus, rash tissue disorders Musculoskeletal Arthralgia, and connective backache tissue disorders General disorders Infusion site and discomfort, administration infusion site site conditions burning, infusion site swelling, injection site sterile abscess, chest discomfort, fever, rigors, fatigue
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-12-01T11:13:00Z · SHA-256 69a92931d7a6103987781141d4940cde8f41b6089f4bedbec222b039bd029e1e · Passage 01fdafe13281689cf9536788a04c4da3241ce18eb54e356fa0cce8557fff6aef · Zeichen 368–2475 im Abschnitt